| Literature DB >> 35127519 |
Marta Araujo-Castro1,2, Alberto Acitores Cancela3, Carlos Vior3, Eider Pascual-Corrales1, Víctor Rodríguez Berrocal3,4.
Abstract
PURPOSE: To evaluate which radiological classification, Knosp, revised-Knosp, or Hardy-Wilson classification, is better for the prediction of surgical outcomes in the endoscopic endonasal transsphenoidal (EET) surgery of pituitary adenomas (PAs).Entities:
Keywords: Hardy-Wilson classification; Knosp classification; endoscopic endonasal transsphenoidal surgery; invasive pituitary adenomas; pituitary adenomas
Year: 2022 PMID: 35127519 PMCID: PMC8810816 DOI: 10.3389/fonc.2021.807040
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Figure 1Study population.
Figure 2Hardy–Wilson and Knosp classifications. Hardy–Wilson classification considered the degree of sellar destruction: Grade 0 when the adenoma remains within the anatomical confines of the osteoaponeural sheath of the sella turcica; Grade I: the sella turcica is within normal limits in size or focally expanded and the tumor is <10 mm; Grade II: tumor ≥ 10 mm and the sella turcica is enlarged but the floor remains intact; Grade III: a local erosion or destruction of the floor; Grade IV when the entire floor of the sella is diffusely eroded or destroyed. Extrasellar extension according to Hardy–Wilson is divided in stage 0, with no suprasellar extension, A–C for progressive suprasellar extension. Knosp–Steiner classification considered: Knosp 0 when PA is medial to medial tangent; Knosp 1 if PA extends to the space between the medial tangent and the intercarotid line; Knosp 2 when PA extends to the space between the intercarotid line and the lateral tangent; Knosp 3 if PA extends lateral to the lateral tangent; and Knosp 4 with a complete encasement of intracavernous ICA. Knosp score 3–4 were considered as invasive PA. The revised-Knosp classification includes Knosp 3A when PA is above the intracavernous ICA into the superior cavernous sinus compartment and Knosp 3B when PA is below the intracavernous ICA into the inferior cavernous sinus compartment.
Figure 3Intraoperative–radiologic correlation of cavernous sinus invasion in pituitary adenomas. ICA is highlighted in yellow dotted line and differently affected CS compartments are pointed out (white stars). Case 1: Right superior compartment invasion of the cavernous sinus (Knosp 3A) in an acromegalic patient. Preoperative MRI (A1) and intraoperative view through a 45° endoscope (A2) after tumor resection (left cavernous sinus medial wall resected in blue dotted line). The patient was cured after surgery. Case 2: Left Inferior compartment invasion of the CS in a resistant prolactin-secreting PA (Knosp 3B). Preoperative MRI (B1) and intraoperative view through a 0° endoscope (B2) after tumor resection showing anterior CS wall resection (green dotted line). Case 3: Complete cavernous sinus invasion (Knosp 4) in an acromegalic patient. Preoperative MRI in T2 sequences (C1, C2) shows a complete ICA encasement and the postoperative coronal MRI (C3) shows a near total resection. Intraoperative view through a 45° endoscope (C4) after tumor resection showing ICA and superior and inferior compartment. No surgical cure was achieved.
Patient and tumor characteristics of the study cohort at diagnosis.
| Characteristic | Value |
|---|---|
| Age (years) | 52.9 ± 15.4 |
| Female sex | 52.2% ( |
| Diabetes mellitus | 13.2% ( |
| High blood pressure | 30.7% ( |
| Obesity | 10.5% ( |
| Heart disease | 8.3% ( |
| Sleep apnea syndrome | 7.9% ( |
| Headache | 22.8% ( |
| Visual involvement | 34.7% ( |
| Pituitary apoplexy | 6.6% ( |
| Hypopituitarism | 37.3% ( |
| Macroadenomas | 86.3% ( |
| Knosp grade > 2/Hardy stage E | 35.1% ( |
| Hardy grade > II ( | 74.6% ( |
| Cranio-caudal diameter (mm) | 20.7 ± 12.3 |
| Latero-lateral diameter (mm) | 19.0 ± 10.0 |
| Total tumor resection in non-functioning PAs | 69.3% ( |
| Biochemical cure in functioning PAs | 65.9% ( |
| Postoperative permanent diabetes insipidus | 4.8% ( |
| Cerebrospinal fluid leakage | 5.3% ( |
| Postoperative new anterior pituitary deficits | 13.3% ( |
| Hard consistency ( | 28.9% ( |
Invasion Hardy classification (sella destruction) was available only in 173 patients.
Differences in clinical, hormonal, radiological, and histological features of invasive and non-invasive pituitary adenomas.
| Variable | Knosp and extension Hardy classifications | ||
|---|---|---|---|
| Knosp ≤ 2/Hardy A–C ( | Knosp > 2/Hardy E ( |
| |
|
| 52.5 ± 15.3 | 53.5 ± 15.6 | 0.628 |
|
| 54.7% | 47.5% | 0.297 |
|
| 19.6% | 28.8% | 0.116 |
|
| 24.3% | 53.8% | <0.0001 |
|
| 14.9 ± 7.4 | 26.5 ± 9.7 | <0.0001 |
|
| 16.2 ± 9.4 | 29.3 ± 12.7 | <0.0001 |
|
| 19.6% | 21.3% | 0.766 |
|
| 41.9% | 32.5% | 0.164 |
|
| 0.7% ( | 7.5% ( | 0.004 |
|
| 23.6% ( | 38.5% ( | 0.020 |
|
| 7.4% ( | 12.5% ( | 0.207 |
L-L diameter, latero-lateral diameter; C-C diameter, cranio-caudal diameter; PA, pituitary adenoma.
Surgical outcomes according to cavernous sinus invasion based on Knosp and revised-Knosp classifications.
| Variable | Knosp classification | Revised-Knosp classification | ||||
|---|---|---|---|---|---|---|
| Knosp ≤ 2 ( | Knosp > 2 ( |
| Knosp 3A ( | Knosp 3B ( |
| |
|
| 80.2% (69/86) | 31.9% (19/54) | <0.0001 | 68.8% (11/16) | 33.3% (3/9) | 0.087 |
|
| 87.1% (54/62) | 15.4% (4/26) | <0.0001 | 33.3% (3/9) | 0% (0/1) | 0.490 |
|
| 10.3% (10/97) | 20.0% (9/46) | 0.115 | 16.7% (2/12) | 12.5% (1/8) | 0.798 |
|
| 4.7% (7/148) | 5.0% (4/80) | 0.911 | 0% (0/25) | 10% (1/10) | 0.109 |
|
| 3.4% (5/148) | 13.8% (11/80) | 0.003 | 8.0% (2/25) | 10.0% (1/10) | 0.849 |
|
| 2.7% (4/148) | 10.0% (8/80) | 0.017 | 4.0% (1/25) | 10.0% (1/10) | 0.490 |
|
| 6.1% (9/148) | 5.0% (4/80) | 0.913 | 8.0% (2/25) | 0% (0/10) | 0.357 |
Figure 4Surgical remission in functioning pituitary adenomas and total resection in non-functioning pituitary adenomas based on Knosp and Hardy classifications.
Surgical outcome based on the Knosp and revised-Knosp classifications.
| Knosp | Surgical remission | Major complications | Risk of non-cure, 95% CI (considering Knosp 0 as reference) |
|---|---|---|---|
| 0 | 86.5% (45/52) | 0% (0/52) | 1 |
| 1 | 88.6% (31/35) | 2.9% (1/35) | 0.97 [0.25–3.72] |
| 2 | 77.1% (47/61) | 6.6% (4/61) | 2.23 [0.79–6.32] |
| 3 | 46.0% (17/37) | 8.1% (3/37) | 4.59 [2.05–10.31] |
| 3A | 56.0% (14/25) | 8.0% (2/25) | 5.89 [1.84–12.82] |
| 3B | 30.0% (3/10) | 10.0% (1/10) | 17.5 [3.54–86.54] |
| 4 | 14.0% (6/43) | 18.6% (8/43) | 46.25 [13.76–155.46] |
| Total | 64.3% (146/228) | 7.0% (16/228) |
The chances of non-cure increased as the Knosp grade increased [MH Test for linear Trend: χ2 = 73.1 (p = 0.0000)].
Surgical outcome based on the invasion and extension Hardy classification.
| Surgical remission | Major complications | |
|---|---|---|
|
| ||
| 0 | 100% (5/5) | 0% (0/5) |
| I | 100% (1/1) | 0% (0/1) |
| II | 79.0% (30/38) | 5.3% (2/38) |
| III | 66.3% (67/101) | 10.9% (11/101) |
| IV | 35.7% (10/28) | 7.1% (2/28) |
|
| ||
| A–D | 83.1% (123/148) | 3.4% (5/148) |
| E | 28.8% (23/80) | 13.8% (11/80) |
|
| 64.3% (146/228) | 7.0% (16/228) |
Figure 5Diagnostic accuracy of the Knosp and Hardy scales for the prediction of surgical cure. (a1) AUC of the Knosp scale for the prediction of surgical failure: 0.820 [0.760–0.879]; optimal cutoff for the prediction of failure: Knosp 3 [sensitivity (Se) = 70.4% (59.7–79.2), specificity (Sp) = 84.2% (77.5–89.3); a2] AUC of the revised-Knosp scale for the prediction of surgical failure: 0.820 [0.760–0.882]; optimal cutoff for the prediction of failure: Knosp 3A [Se= 68.8% (57.8–78.1), Sp = 84.8% (78.1–89.8); a3] AUC of the invasion Hardy scale for the prediction of surgical failure: 0.654 [0.580–0.728]; optimal cutoff for the prediction of failure: Hardy IV [Se = 86.7% (75.8–93.1), Sp = 31.9% (24.0–40.9); a4] AUC of the extension Hardy scale (A–D vs. E) for the prediction of surgical failure: 0.732 [0.672–0.793]; optimal cutoff for the prediction of failure: Hardy stage E [Se = 62.2% (51.4–71.9), Sp = 84.2% (77.5–89.3)].